Skip to content

The therapeutic effect of erbium laser on wrinkles and laxity around the eyes

Clinical safety and efficacy of 2940nm erbium laser in treating periorbital wrinkles and laxity

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500108823
Enrollment
Unknown
Registered
2025-09-05
Start date
2025-07-25
Completion date
Unknown
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Skin aging: periorbital wrinkles and laxity

Interventions

Group B:Fractional erbium laser,density:10%
Fluence:100-150J/cm^2
Group A:Fractional erbium laser,density:15%

Sponsors

Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged 35-65 with indications for static wrinkles and sagging of the skin around the eyes, regardless of gender; 2. The eye area has never received any other treatment; 3. After fully understanding the treatment plan and risks, I or my guardian voluntarily sign an informed consent form, willing to accept a randomized half face controlled trial, and cooperate with follow-up.

Exclusion criteria

Exclusion criteria: 1. Pregnant women or women with preconception plans; 2. Allergic to surface disinfectants; 3. Patients with facial wounds or epidermal rupture; 4. Patients with severe organic or mental illnesses; 5. Patients currently participating in other clinical trials. 6. Having serious skin diseases; 7. History of allergies to laser therapy, etc.

Design outcomes

Primary

MeasureTime frame
Global Aesthetic Improvement Scale (GAIS);

Secondary

MeasureTime frame
Satisfaction Assesment Sacle;Lemperle wrinkle scale;VISIA Skin Analysis System objectively quantifies and evaluates relevant parameters;

Countries

China

Contacts

Public ContactLin Xiaoxi

Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine

linxiaoxi@126.com+86 137 0199 7136

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026